Revenues down 12.7%
Consulting, finance and legal costs up $1m
Net foreign exchange loss of $0.25m
APAC and NZ gone.
We're basically in September so Oncosil must have about $2.5m in cash at their current burn rate? Does that mean they are at risk of being delisted?
Interestingly, APAC has a revenue of $15k... my guess is that is roughly what a single dose costs.
Not looking good fellas.
Ann: Appendix 4E Preliminary Financial Report, page-3
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.001(14.3%) |
Mkt cap ! $35.79M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.8¢ | $176.5K | 22.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 55 | 24495733 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 11069552 | 12 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| OSL (ASX) Chart |